Kolexia
Bouchet Stephane
Pharmacien
Hôpital Pellegrin
Bordeaux, France
82 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémie myéloïde chronique BCR-ABL positive Leucémies Leucémie myéloïde COVID-19 Fibrose Infections à coronavirus Mucoviscidose Pneumopathie virale Néphrocarcinome

Industries

Pierre Fabre
1 collaboration(s)
Dernière en 2020
Gilead
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
British journal of clinical pharmacology   21 août 2023
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
The Journal of antimicrobial chemotherapy   03 mars 2023
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
British journal of haematology   10 octobre 2022
A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case.
Journal of the American Society for Mass Spectrometry   09 septembre 2022
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia.
Pharmaceutics   12 août 2022
Clinical impact of early intra-individual variability of tacrolimus trough concentrations after renal transplantation: Preliminary results of the VIPATIA study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 14–16 June 2022, Lille, France   05 juin 2022
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT).
Therapie   20 avril 2022
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   15 mars 2022
COVERAGEFrance: Randomized Trial to Evaluate the Safety and Efficacy of Outpatient Treatments to Reduce the Risk of Worsening in Individuals With COVID-19 With Risk Factors (COVERAGE France)
Essai Clinique (CHU Bordeaux)   03 février 2022
Pharmacokinetics and therapeutic drug monitoring of anticancer protein/kinase inhibitors.
Therapie   06 décembre 2021